{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:39:54Z","timestamp":1792226394678,"version":"4.4.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10096-025-05110-y","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:09:45Z","timestamp":1742684985000},"page":"1289-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A review of historical landmarks and pioneering technologies for the diagnosis of Hepatitis C Virus (HCV)"],"prefix":"10.1007","volume":"44","author":[{"given":"Kajal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meesala Krishna","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"5110_CR1","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1097\/00007890-199806270-00431","volume":"65","author":"K Aardema","year":"1998","unstructured":"Aardema K, Moonka D, Terry L, Brown K, Ma C, Abouljoud M, Nakhleh R, Burd E (1998) Quantitation of hepatitis c virus rna in liver tissue of allografts: correlation with histologic features and liver function tests. Transplantation 65:S105","journal-title":"Transplantation"},{"key":"5110_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/BOR.0000000000001015","volume":"36","author":"LC Adams","year":"2024","unstructured":"Adams LC, Poddubnyy D, Bressem KK, Poddubnyy D (2024) Artificial intelligence and machine learning in axial spondyloarthritis. Curr Opin Rheumatol 36:267\u2013273","journal-title":"Curr Opin Rheumatol"},{"key":"5110_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/hepr.12385","volume":"45","author":"M Alboraie","year":"2014","unstructured":"Alboraie M, Esmat G, Khairy M, Asem N, Elsharkawy A, Elsharkawy M (2014) Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns\u2019 index in chronic hepatitis C virus. Hepatol Res 45:560\u2013570","journal-title":"Hepatol Res"},{"key":"5110_CR4","doi-asserted-by":"crossref","unstructured":"Alter HJ (2019) From B to Non-B to C: The Hepatitis C Virus in Historical Perspective. Springer, pp 3\u201317","DOI":"10.1007\/7355_2018_33"},{"key":"5110_CR5","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/j.1462-5822.2007.00972.x","volume":"9","author":"U Andr\u00e9o","year":"2007","unstructured":"Andr\u00e9o U, Kalinina O, Maillard P, Martinot M, Budkowska A, Walic M, Marcellin P, Meurs E (2007) Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol 9:2445\u20132456","journal-title":"Cell Microbiol"},{"key":"5110_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s40273-021-01064-z","volume":"39","author":"B Asker","year":"2021","unstructured":"Asker B, Jawad R, Asreah R, Jamal H, Jassem A, Inaya MA, Baker HA, Kozma S, Mansour E, McNamara B, Miller R (2021) Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment. Pharmacoeconomics 39:1327\u20131341","journal-title":"Pharmacoeconomics"},{"key":"5110_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/5156601","volume":"2023","author":"AA Awadh","year":"2023","unstructured":"Awadh AA, Samrat S (2023) The Role of Cytosolic Lipid Droplets in Hepatitis C Virus Replication, Assembly, and Release. Biomed Res Int 2023:1\u201315","journal-title":"Biomed Res Int"},{"issue":"1","key":"5110_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13036-024-00443-2","volume":"18","author":"AS Baber","year":"2024","unstructured":"Baber AS, Suganthan B, Ramasamy RP (2024) Current advances in Hepatitis C diagnostics. J Biol Eng 18(1):48","journal-title":"J Biol Eng"},{"key":"5110_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/QAD.0b013e32834fa121","volume":"26","author":"K Bambha","year":"2012","unstructured":"Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD (2012) Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 26:599\u2013607","journal-title":"AIDS"},{"key":"5110_CR10","unstructured":"Bao Y, Xiao Y (2018) Application and quality management of high-throughput sequencing in clinical molecular diagnosis of five kinds of diseases. 6:69\u201373"},{"key":"5110_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14740\/gr1347","volume":"14","author":"F Bert","year":"2021","unstructured":"Bert F, Parpalea A-L, Rossol S, Stahmeyer JT (2021) Non-invasive reliable methods to objectify the positive influence of hepatitis C virus treatment on liver stiffness. Gastroenterology Res 14:31\u201340","journal-title":"Gastroenterology Res"},{"key":"5110_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0399-8320(08)73996-4","volume":"32","author":"M Bourli\u00e8re","year":"2008","unstructured":"Bourli\u00e8re M, P\u00e9naranda G, Adhoute X, Oules V, Castellani P (2008) Combining non-invasive methods for assessment of liver fibrosis. Gastroenterol Clin Biol 32:73\u201379","journal-title":"Gastroenterol Clin Biol"},{"key":"5110_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmi.2021.06.042","volume":"28","author":"D Bradshaw","year":"2021","unstructured":"Bradshaw D, Bibby DF, Manso CF, Piorkowska R, Mohamed H, Ledesma J, Bubba L, Chan YT, Ngui SL, Carne S, Mbisa JL (2021) Clinical evaluation of a Hepatitis C Virus whole-genome sequencing pipeline for genotyping and resistance testing. Clin Microbiol Infect 28:405\u2013409","journal-title":"Clin Microbiol Infect"},{"key":"5110_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1099\/vir.0.008300-0","volume":"90","author":"ME Burlone","year":"2009","unstructured":"Burlone ME, Budkowska A (2009) Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 90:1055\u20131070","journal-title":"J Gen Virol"},{"key":"5110_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-2000-9939","volume":"20","author":"RL Carithers Jr","year":"2000","unstructured":"Carithers RL Jr, Marquardt A, Gretch DR (2000) Diagnostic testing for hepatitis C. Semin Liver Dis 20:159\u2013172","journal-title":"Semin Liver Dis"},{"key":"5110_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/jiaa442","volume":"223","author":"B Catlett","year":"2020","unstructured":"Catlett B, Cunningham PH, Applegate TL, Bajis S, Hajarizadeh B, Starr M, Grebely J, Dore GJ (2020) Evaluation of the Aptima HCV Quant Dx assay for Hepatitis C VIrus RNA detection from fingerstick capillary dried blood spot and venepuncture-collected samples. J Infect Dis 223:818\u2013826","journal-title":"J Infect Dis"},{"key":"5110_CR17","doi-asserted-by":"publisher","first-page":"083001","DOI":"10.1088\/1361-6439\/aa7117","volume":"27","author":"S Chen","year":"2017","unstructured":"Chen S, Shamsi MH (2017) Biosensors-on-chip: a topical review. J Micromech Microeng 27:083001","journal-title":"J Micromech Microeng"},{"key":"5110_CR18","doi-asserted-by":"publisher","first-page":"459.e1","DOI":"10.1016\/j.cmi.2016.01.009","volume":"22","author":"S Chevaliez","year":"2016","unstructured":"Chevaliez S, Poiteau L, Rosa I, Soulier A, Roudot-Thoraval F, Laperche S, H\u00e9zode C, Pawlotsky JM (2016) Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care. Clin Microbiol Infect 22:459.e1-459.e6","journal-title":"Clin Microbiol Infect"},{"key":"5110_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/tid.12526","volume":"18","author":"G Crespo","year":"2016","unstructured":"Crespo G, Gambato M, Mill\u00e1n O, Casals G, Ruiz P, Londo\u00f1o MC, Mira A, Forns X, Brunet M, Jim\u00e9nez W, Navasa M (2016) Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation. Transpl Infect Dis 18:471\u2013479","journal-title":"Transpl Infect Dis"},{"key":"5110_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/rmv.1895","volume":"26","author":"L Cuypers","year":"2016","unstructured":"Cuypers L, Rockstroh JK, Li G, Ceccherini-Silberstein F, Vandamme A, Van Laethem K (2016) Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time. Rev Med Virol 26:408\u2013434","journal-title":"Rev Med Virol"},{"key":"5110_CR21","doi-asserted-by":"publisher","first-page":"114470","DOI":"10.1016\/j.jviromet.2022.114470","volume":"302","author":"AC da Fonseca Mendon\u00e7a","year":"2022","unstructured":"da Fonseca Mendon\u00e7a AC, Portilho MM, da Silva JC, Caetano AR, Lewis-Ximenez LL, Villar LM (2022) Optimization of a real time PCR methodology for HCV RNA quantification in saliva samples. J Virol Methods 302:114470","journal-title":"J Virol Methods"},{"issue":"9","key":"5110_CR22","doi-asserted-by":"crossref","first-page":"e12274","DOI":"10.5812\/hepatmon.12274","volume":"13","author":"L Da Rosa","year":"2013","unstructured":"Da Rosa L, Dantas-Corr\u00eaa EB, Schiavon LDL, Narciso-Schiavon JL (2013) Diagnostic performance of two point-of-care tests for Anti-HCV detection. Hepat Mon 13(9):e12274","journal-title":"Hepat Mon"},{"key":"5110_CR23","doi-asserted-by":"crossref","unstructured":"Dammacco F, Racanelli V (2011) Mechanisms of cell entry of hepatitis C virus. springer milan, pp 63\u201368","DOI":"10.1007\/978-88-470-1705-4_7"},{"key":"5110_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1586\/erd.10.46","volume":"7","author":"V De L\u00e9dinghen","year":"2010","unstructured":"De L\u00e9dinghen V, Vergniol J (2010) Transient elastography for the diagnosis of liver fibrosis. Expert Rev Med Devices 7:811\u2013823","journal-title":"Expert Rev Med Devices"},{"key":"5110_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0272-6386(12)70224-X","volume":"20","author":"M De Medina","year":"1992","unstructured":"De Medina M, Ortiz C, Krenc C et al (1992) Improved detection of antibodies to hepatitis C virus in dialysis patients using a second-generation enzyme immunoassay. Am J Kidney Dis 20:589\u2013591","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"5110_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jcv.2014.04.001","volume":"60","author":"SL de Paula","year":"2014","unstructured":"de Paula SL, Cruz HM, de Paula VS, Miguel JC, Marques VA, Villela-Nogueira CA, Milagres FA, Cruz MS, Bastos FI, Andrade TM, Motta-Castro AR (2014) Performance of rapid hepatitis C virus antibody assays among high-and low-risk populations. J Clin Virol 60(3):200\u2013205","journal-title":"J Clin Virol"},{"key":"5110_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11938-019-00240-7","volume":"17","author":"RK Dhiman","year":"2019","unstructured":"Dhiman RK, Grover GS, Premkumar M (2019) Hepatitis C elimination: a Public Health Perspective. Curr Treat Options Gastroenterol 17:367\u2013377","journal-title":"Curr Treat Options Gastroenterol"},{"key":"5110_CR28","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3390\/v14091929","volume":"14","author":"W Dimech","year":"2022","unstructured":"Dimech W, Cabuang L, Davies K, Vincini G (2022) Implementation of novel quality assurance program for hepatitis C viral load point of care testing. Viruses 14:1929","journal-title":"Viruses"},{"key":"5110_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.chom.2014.10.009","volume":"16","author":"Q Ding","year":"2014","unstructured":"Ding Q, Ploss A, Von Schaewen M (2014) The impact of hepatitis C virus entry on viral tropism. Cell Host Microbe 16:562\u2013568","journal-title":"Cell Host Microbe"},{"key":"5110_CR30","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1099\/jgv.0.000283","volume":"96","author":"P Domingues","year":"2015","unstructured":"Domingues P, Bamford CGG, Boutell C, Mclauchlan J (2015) Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase. J Gen Virol 96:3236\u20133242","journal-title":"J Gen Virol"},{"key":"5110_CR31","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.jhep.2016.08.002","volume":"65","author":"PJ Easterbrook","year":"2016","unstructured":"Easterbrook PJ (2016) Who to test and how to test for chronic hepatitis C infection \u2013 2016 WHO testing guidance for low- and middle-income countries. J Hepatol 65:S46\u2013S66","journal-title":"J Hepatol"},{"key":"5110_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/COH.0000000000000370","volume":"12","author":"PJ Easterbrook","year":"2017","unstructured":"Easterbrook PJ, Peeling R, Sands A, Roberts T (2017) Diagnosis of viral hepatitis. Curr Opin HIV AIDS 12:302\u2013314","journal-title":"Curr Opin HIV AIDS"},{"key":"5110_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1386-6532(00)00170-0","volume":"21","author":"S Erensoy","year":"2001","unstructured":"Erensoy S (2001) Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. J Clin Virol: Off Publ Pan Am Soc Clin Virol 21:271\u2013281","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"issue":"2","key":"5110_CR34","doi-asserted-by":"publisher","first-page":"e2514","DOI":"10.1002\/rmv.2514","volume":"34","author":"AN Farrag","year":"2024","unstructured":"Farrag AN, Kamel AM, El-Baraky IA (2024) Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: the example of chronic hepatitis C virus. Rev Med Virol 34(2):e2514","journal-title":"Rev Med Virol"},{"key":"5110_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2174\/1389450116666150825111314","volume":"18","author":"JJ Feld","year":"2017","unstructured":"Feld JJ (2017) Direct-acting antivirals for Hepatitis C Virus (HCV): the progress continues. Curr Drug Targets 18:851\u2013862","journal-title":"Curr Drug Targets"},{"key":"5110_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5501\/wjv.v4.i1.25","volume":"4","author":"R Firdaus","year":"2015","unstructured":"Firdaus R (2015) Current molecular methods for the detection of hepatitis C virus in high risk group population: a systematic review. World Journal of Virology 4:25","journal-title":"World Journal of Virology"},{"issue":"8","key":"5110_CR37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jmv.24777","volume":"89","author":"GL Flores","year":"2017","unstructured":"Flores GL, Cruz HM, Marques VA, Villela-Nogueira CA, Potsch DV, May SB, Brand\u00e3o-Mello CE, Pires MM, Pilotto JH, Pollo-Flores P, Esberard EB (2017) Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status. J Med Virol 89(8):1435\u20131441","journal-title":"J Med Virol"},{"issue":"4","key":"5110_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4254\/wjh.v13.i4.504","volume":"13","author":"GL Flores","year":"2021","unstructured":"Flores GL, Barbosa JR, Cruz HM, Miguel JC, Potsch DV, Pilotto JH, Lima DM, Colares JK, Brand\u00e3o-Mello CE, Pires MM, da Mota JC (2021) Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations. World J Hepatol 13(4):504","journal-title":"World J Hepatol"},{"issue":"2","key":"5110_CR39","doi-asserted-by":"publisher","first-page":"104512","DOI":"10.1016\/j.bjid.2025.104512","volume":"29","author":"G Flores","year":"2025","unstructured":"Flores G, Lago BV, Caetano AR, Silva J, Marques V, Brand\u00e3o-Mello CE, Amendola-Pires M, Pilotto J, Lewis-Ximenez L, Villar LM (2025) Dried blood spot as alternative specimen for molecular epidemiology studies among HCV\/HIV coinfected patients. Braz J Infect Dis 29(2):104512","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"5110_CR40","doi-asserted-by":"publisher","first-page":"12507","DOI":"10.1038\/s41598-019-48966-9","volume":"9","author":"M Fr\u00edas","year":"2019","unstructured":"Fr\u00edas M, Rivero-Ju\u00e1rez A, T\u00e9llez F, Palacios R, Jim\u00e9nez-Arranz \u00c1, Pineda JA, Merino D, G\u00f3mez-Vidal MA, P\u00e9rez-Camacho I, Camacho \u00c1, Rivero A (2019) Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR. Sci Rep 9(1):12507","journal-title":"Sci Rep"},{"key":"5110_CR41","doi-asserted-by":"publisher","first-page":"S362","DOI":"10.1093\/infdis\/jiad177","volume":"229","author":"GP Fricker","year":"2023","unstructured":"Fricker GP, Mera J, Pinsky BA, Chung RT, Ward JW, Ghany MG (2023) Tools needed to support same-day diagnosis and treatment of current hepatitis C virus infection. J Infect Dis 229:S362\u2013S369","journal-title":"J Infect Dis"},{"key":"5110_CR42","first-page":"237","volume":"439","author":"A Galli","year":"2023","unstructured":"Galli A, Bukh J (2023) Mechanisms and consequences of genetic variation in Hepatitis C Virus (HCV). Curr Top Microbiol Immunol 439:237\u2013264","journal-title":"Curr Top Microbiol Immunol"},{"key":"5110_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1515\/cclm-2017-0754","volume":"56","author":"C Galli","year":"2018","unstructured":"Galli C, Julicher P, Plebani M (2018) HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection. Clin Chem Lab Med (CCLM) 56:880\u2013888","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"5110_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1574-6976.1994.tb00093.x","volume":"14","author":"JA Garson","year":"1994","unstructured":"Garson JA (1994) The polymerase chain reaction and hepatitis C virus diagnosis. FEMS Microbiol Rev 14:229\u2013239","journal-title":"FEMS Microbiol Rev"},{"key":"5110_CR45","first-page":"2161","volume":"161","author":"KV Gaspareto","year":"2016","unstructured":"Gaspareto KV, Gomes-Gouv\u00eaa MS, Pinho JRR, Muto NH, Carrilho FJ, De Mello MF, Sabino EC, Mendes-Correa MC, Rozanski A, Ribeiro RM (2016) HCV inter-subtype 1a\/1b recombinant detected by complete-genome next-generation sequencing. Adv Virol 161:2161\u20132168","journal-title":"Adv Virol"},{"key":"5110_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0025-6196(11)62111-3","volume":"76","author":"JJ Germer","year":"2001","unstructured":"Germer JJ, Zein NN (2001) Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 76:911\u2013920","journal-title":"Mayo Clin Proc"},{"key":"5110_CR47","doi-asserted-by":"publisher","first-page":"a036830","DOI":"10.1101\/cshperspect.a036830","volume":"10","author":"G Gerold","year":"2019","unstructured":"Gerold G, Pietschmann T, Moeller R (2019) Hepatitis C virus entry: protein interactions and fusion determinants governing productive hepatocyte invasion. Cold Spring Harb Perspect Med 10:a036830","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5110_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00018-016-2377-9","volume":"74","author":"GK Gerresheim","year":"2016","unstructured":"Gerresheim GK, Niepmann M, D\u00fcnnes N, Nieder-R\u00f6hrmann A, H\u00f6ner Zu Siederdissen C, Marz M, Hofacker I, Shalamova LA, Fricke M (2016) microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3\u2019 untranslated region: function in replication and influence of RNA secondary structure. Cell Mol Life Sci 74:747\u2013760","journal-title":"Cell Mol Life Sci"},{"key":"5110_CR49","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.3390\/ijms21186955","volume":"21","author":"GK Gerresheim","year":"2020","unstructured":"Gerresheim GK, Niepmann M, Shatsky IN, Andreev DE, Shalamova LA, Hess CS, Fricke M, Marz M (2020) Ribosome pausing at inefficient codons at the end of the replicase coding region is important for hepatitis C virus genome replication. Int J Mol Sci 21:6955","journal-title":"Int J Mol Sci"},{"key":"5110_CR50","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jcla.21873","volume":"30","author":"S Gong","year":"2015","unstructured":"Gong S, Zhou L, Schmotzer CL (2015) Evaluation of quantitative real-time PCR as a hepatitis C virus supplementary test after RIBA discontinuation. J Clin Lab Anal 30:418\u2013423","journal-title":"J Clin Lab Anal"},{"key":"5110_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jmv.25617","volume":"92","author":"P Grabarczyk","year":"2019","unstructured":"Grabarczyk P, Laskus T, Zwoli\u0144ska P et al (2019) Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations. J Med Virol 92:339\u2013347","journal-title":"J Med Virol"},{"key":"5110_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2019.07.016","volume":"72","author":"J Grebely","year":"2019","unstructured":"Grebely J, Hajarizadeh B, Lazarus JV, Bruneau J, Treloar C (2019) Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all. Int J Drug Policy 72:1\u201310","journal-title":"Int J Drug Policy"},{"key":"5110_CR53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1089-3261(05)70320-2","volume":"1","author":"DR Gretch","year":"1997","unstructured":"Gretch DR (1997) Use and interpretation of hcv diagnostic tests in the clinical setting. Clin Liver Dis 1:543\u2013557","journal-title":"Clin Liver Dis"},{"key":"5110_CR54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.51821\/84.4.015","volume":"84","author":"P Guntipalli","year":"2021","unstructured":"Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel MK, Razzack AA, Solimando AG, Thompson A, Andrews K (2021) Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastro-Enterol Belg 84:633\u2013652","journal-title":"Acta Gastro-Enterol Belg"},{"issue":"9","key":"5110_CR55","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/nano10091645","volume":"10","author":"S Gurunathan","year":"2020","unstructured":"Gurunathan S, Qasim M, Choi Y, Do JT, Park C, Hong K, Kim JH, Song H (2020) Antiviral potential of nanoparticles\u2014can nanoparticles fight against coronaviruses? Nanomaterials 10(9):1645","journal-title":"Nanomaterials"},{"key":"5110_CR56","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/j.1440-1746.2006.04614.x","volume":"22","author":"E Hadlich","year":"2007","unstructured":"Hadlich E, Goldani LZ, Zenker R, Molin RKD, \u00c1lvares-Da-Silva MR (2007) Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies detectable by third-generation enzyme immunoassay. J Gastroenterol Hepatol 22:1506\u20131509","journal-title":"J Gastroenterol Hepatol"},{"key":"5110_CR57","doi-asserted-by":"crossref","unstructured":"Hafez TA (2017) Public Health and Economic Burden of Hepatitis C Infection in Developing Countries. In: Hepatitis C in Developing Countries. Elsevier, pp 25\u201332","DOI":"10.1016\/B978-0-12-803233-6.00003-5"},{"key":"5110_CR58","doi-asserted-by":"publisher","first-page":"e0242028","DOI":"10.1371\/journal.pone.0242028","volume":"15","author":"H Haga","year":"2020","unstructured":"Haga H, Okumoto K, Koseki A, Katsumi T, Nishina T, Sato H, Mizuno K, Ueno Y, Saito T, Hoshikawa K (2020) A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus. PLoS ONE 15:e0242028","journal-title":"PLoS ONE"},{"key":"5110_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5472\/MMJsi.2901.03","volume":"29","author":"G Haklar","year":"2016","unstructured":"Haklar G (2016) Liver function tests in chronic viral hepatitis cases. Marmara Med J 29:6","journal-title":"Marmara Med J"},{"key":"5110_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1071\/MA10119","volume":"31","author":"G Higgins","year":"2010","unstructured":"Higgins G (2010) Pitfalls of viral load testing. Microbiol Aust 31:119","journal-title":"Microbiol Aust"},{"issue":"22","key":"5110_CR61","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, Kitano TK (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83(22):8604\u20138610","journal-title":"Anal Chem"},{"issue":"1","key":"5110_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/liv.14363","volume":"40","author":"C Hollande","year":"2020","unstructured":"Hollande C, Parlati L, Pol S (2020) Micro-elimination of hepatitis C virus. Liver Int Suppl 40(1):67\u201371","journal-title":"Liver Int Suppl"},{"key":"5110_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/rmv.717","volume":"22","author":"S Hosseini-Moghaddam","year":"2011","unstructured":"Hosseini-Moghaddam S, Mazzulli T, Rotstein C, Husain S, Iran-Pour E, Renner E, Lilly L (2011) Hepatitis C core Ag and its clinical applicability: Potential advantages and disadvantages for diagnosis and follow-up? Rev Med Virol 22:156\u2013165","journal-title":"Rev Med Virol"},{"key":"5110_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jvh.13664","volume":"29","author":"J Howell","year":"2022","unstructured":"Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J (2022) The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study. J Viral Hepatitis 29:375\u2013384","journal-title":"J Viral Hepatitis"},{"key":"5110_CR65","first-page":"333","volume":"42","author":"W Hua","year":"2019","unstructured":"Hua W, Sheng LJ, Wang Q (2019) Point-of-care testing in the diagnosis of infectious diseases. Chin J Lab Med 42:333\u2013337","journal-title":"Chin J Lab Med"},{"key":"5110_CR66","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ajpath.2023.11.017","volume":"194","author":"BR Huckestein","year":"2023","unstructured":"Huckestein BR, Zeng K, Westcott R, Alder JK, Antos D, Kolls JK, Alcorn JF (2023) Mammalian target of rapamycin complex 1 activation in macrophages contributes to persistent lung inflammation following respiratory tract viral infection. Am J Pathol 194:384\u2013401","journal-title":"Am J Pathol"},{"key":"5110_CR67","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1093\/infdis\/jiad463","volume":"229","author":"E Ivanova Reipold","year":"2023","unstructured":"Ivanova Reipold E, Donolato M, Fernandez Suarez M, Shilton S (2023) Molecular point-of-care testing for hepatitis C: available technologies, pipeline, and promising future directions. J Infect Dis 229:S342\u2013S349","journal-title":"J Infect Dis"},{"key":"5110_CR68","first-page":"1621","volume":"24","author":"GM Jamali","year":"2017","unstructured":"Jamali GM, Jamali AA, Shaikh H (2017) Hepatitis C Virus. Prof Med J 24:1621\u20131629","journal-title":"Prof Med J"},{"key":"5110_CR69","doi-asserted-by":"publisher","first-page":"e0235036","DOI":"10.1371\/journal.pone.0235036","volume":"15","author":"G Jargalsaikhan","year":"2020","unstructured":"Jargalsaikhan G, Eichner M, Boldbaatar D, Bat-Ulzii P, Lkhagva-Ochir O, Oidovsambuu O, Dashtseren B, Namjil E, Genden Z, Yagaanbuyant D, Tuya A (2020) Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples. PLoS ONE 15:e0235036","journal-title":"PLoS ONE"},{"key":"5110_CR70","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.1093\/infdis\/jiad191","volume":"229","author":"LN Johnson","year":"2023","unstructured":"Johnson LN, Buss SN, Gaynor AM, Wroblewski K (2023) Maximizing reflexive hepatitis C virus (HCV) RNA testing of HCV antibody-reactive samples within United States public health laboratories. J Infect Dis 229:S357\u2013S361","journal-title":"J Infect Dis"},{"key":"5110_CR71","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/jvh.12969","volume":"25","author":"M K\u00e5berg","year":"2018","unstructured":"K\u00e5berg M, Nav\u00e9r G, Hammarberg A, Weiland O (2018) Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination. J Viral Hepatitis 25:1452\u20131461","journal-title":"J Viral Hepatitis"},{"key":"5110_CR72","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1093\/infdis\/jiae127","volume":"229","author":"S Kamili","year":"2024","unstructured":"Kamili S, Wester C (2024) Advancing diagnosis of current hepatitis C virus infection: a key to hepatitis C elimination in the United States. J Infect Dis 229:S313\u2013S315","journal-title":"J Infect Dis"},{"key":"5110_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/ijmm.IJMM_17_381","volume":"36","author":"N Karabulut","year":"2018","unstructured":"Karabulut N, Alacam S, Yolcu A, Onel M, Agacfidan A (2018) Distribution of hepatitis C virus genotypes in Istanbul, Turkey. Indian J Med Microbiol 36:192\u2013196","journal-title":"Indian J Med Microbiol"},{"key":"5110_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/omi.1.2000.5.129","volume":"5","author":"N Kato","year":"2000","unstructured":"Kato N (2000) Genome of Human Hepatitis C Virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics 5:129\u2013151","journal-title":"Microb Comp Genomics"},{"key":"5110_CR75","unstructured":"Kayingo G (2020) Standard Precautions. In: Essential Clinical Procedures. Elsevier, pp 370\u2013380"},{"key":"5110_CR76","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1177\/147323000903700516","volume":"37","author":"R Kesli","year":"2009","unstructured":"Kesli R, Baykan M, Baysal B, Kurtoglu M, Ozdemir M (2009) Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. J Int Med Res 37:1420\u20131429","journal-title":"J Int Med Res"},{"key":"5110_CR77","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1128\/JCM.05292-11","volume":"49","author":"R Kesli","year":"2011","unstructured":"Kesli R, Kurtoglu MG, Terzi Y, Polat H, Uyar Y (2011) Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results. J Clin Microbiol 49:4089\u20134093","journal-title":"J Clin Microbiol"},{"key":"5110_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4254\/wjh.v8.i1.9","volume":"8","author":"R Khachatoorian","year":"2016","unstructured":"Khachatoorian R (2016) Chaperones in hepatitis C virus infection. World J Hepatol 8:9","journal-title":"World J Hepatol"},{"key":"5110_CR79","doi-asserted-by":"publisher","first-page":"742","DOI":"10.53350\/pjmhs22167742","volume":"16","author":"KU Khan","year":"2022","unstructured":"Khan KU, Khan F, Khan AT, Khalid M, Ishfaq M, Naeem M (2022) Frequency of metabolic syndrome in patients with chronic hepatitis C virus infection. Pak J Med Health Sci 16:742\u2013744","journal-title":"Pak J Med Health Sci"},{"key":"5110_CR80","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tim.2018.04.002","volume":"26","author":"VJ Kinchen","year":"2018","unstructured":"Kinchen VJ, Cox AL, Bailey JR (2018) Can broadly neutralizing monoclonal antibodies lead to a hepatitis C virus vaccine? Trends Microbiol 26:854\u2013864","journal-title":"Trends Microbiol"},{"key":"5110_CR81","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/ijerph16030513","volume":"16","author":"MM Knodel","year":"2019","unstructured":"Knodel MM, Targett-Adams P, Herrmann E, Wittum G, Grillo A (2019) Advanced hepatitis C virus replication PDE models within a realistic intracellular geometric environment. Int J Environ Res Public Health 16:513","journal-title":"Int J Environ Res Public Health"},{"key":"5110_CR82","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/medicina60081295","volume":"60","author":"O Koppandi","year":"2024","unstructured":"Koppandi O, Iov\u0103nescu D, Miu\u021bescu B, Motofelea AC, Jig\u0103u OM, Papoi AI, Burciu C, Gadour E, Vuletici D, Miu\u021bescu E (2024) Prospective assessment of serum lipid alterations in chronic hepatitis C patients treated with direct acting antivirals: insights six months post sustained virological response. Medicina (Kaunas) 60:1295","journal-title":"Medicina (Kaunas)"},{"key":"5110_CR83","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/S0168-8278(05)80430-1","volume":"17","author":"JG Kotwal","year":"1993","unstructured":"Kotwal JG (1993) Routine laboratory diagnosis of hepatitis C virus infection. J Hepatol 17:S83\u2013S89","journal-title":"J Hepatol"},{"key":"5110_CR84","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","volume":"217","author":"FM Lamoury","year":"2018","unstructured":"Lamoury FM, Bajis S, Hajarizadeh B, Marshall AD, Martinello M, Ivanova E, Catlett B, Mowat Y, Marks P, Amin J, Smith J (2018) Evaluation of the Xpert HCV viral load finger-stick point-of-care assay. J Infect Dis 217:1889\u20131896","journal-title":"J Infect Dis"},{"key":"5110_CR85","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17:107\u2013115","journal-title":"Clin Microbiol Infect"},{"key":"5110_CR86","doi-asserted-by":"publisher","first-page":"a036913","DOI":"10.1101\/cshperspect.a036913","volume":"10","author":"JV Lazarus","year":"2019","unstructured":"Lazarus JV, Roel E, Elsharkawy AM (2019) Hepatitis C virus epidemiology and the impact of interferon-free hepatitis C virus therapy. Cold Spring Harb Perspect Med 10:a036913","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5110_CR87","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s12272-012-1001-2","volume":"35","author":"C Lee","year":"2012","unstructured":"Lee C (2012) Roles of phosphoinositides and phosphoinositides kinases in hepatitis C virus RNA replication. Arch Pharmacal Res 35:1701\u20131711","journal-title":"Arch Pharmacal Res"},{"key":"5110_CR88","doi-asserted-by":"publisher","first-page":"A140.2","DOI":"10.1136\/gutjnl-2012-302514b.164","volume":"61","author":"L Lee","year":"2012","unstructured":"Lee L, Clark J, Perrett G, Howard P, Makanjuola D (2012) PMO-164 HCV p22 antigen test: serological response and diagnostic advantages. Gut 61:A140.2-A140","journal-title":"Gut"},{"issue":"1","key":"5110_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/etm.2020.9531","volume":"21","author":"A Leu\u015ftean","year":"2020","unstructured":"Leu\u015ftean A, Popescu C, Tili\u015fcan C, Nichita L, Aram\u0103 V (2020) Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy. Exp Ther Med 21(1):99","journal-title":"Exp Ther Med"},{"key":"5110_CR90","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/v13030520","volume":"13","author":"HC Li","year":"2021","unstructured":"Li HC, Yang CH, Lo SY (2021) Hepatitis C Viral. Replication Complex Viruses 13:520","journal-title":"Replication Complex Viruses"},{"key":"5110_CR91","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1073\/pnas.1602701113","volume":"113","author":"Q Li","year":"2016","unstructured":"Li Q, Sodroski C, Lowey B, Schweitzer CJ, Cha H, Zhang F, Liang TJ (2016) Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci 113:7620\u20137625","journal-title":"Proc Natl Acad Sci"},{"key":"5110_CR92","doi-asserted-by":"publisher","first-page":"1402001","DOI":"10.3389\/fcimb.2024.1402001","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu D, Zhang K, Ren R, Liu Y, Zhang S, Zhang X, Cheng J, Chen L, Huang J (2024) Detection technology and clinical applications of serum viral products of hepatitis B virus infection. Front Cell Infect Microbiol 14:1402001","journal-title":"Front Cell Infect Microbiol"},{"key":"5110_CR93","doi-asserted-by":"crossref","unstructured":"Lohmann V (2013) Hepatitis C Virus RNA Replication. pp 167\u2013198","DOI":"10.1007\/978-3-642-27340-7_7"},{"key":"5110_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymeth.2021.04.025","volume":"201","author":"S Long","year":"2022","unstructured":"Long S, Berkemeier B (2022) Ultrasensitive detection and quantification of viral nucleic acids with Raindance droplet digital PCR (ddPCR). Methods 201:49\u201364","journal-title":"Methods"},{"key":"5110_CR95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jcv.2005.03.006","volume":"35","author":"A Macedodeoliveira","year":"2005","unstructured":"Macedodeoliveira A, White KL, Beecham BD, Leschinsky DP, Foley BP, Dockter J, Giachetti C, Safranek TJ (2005) Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients. J Clin Virol 35:21\u201325","journal-title":"J Clin Virol"},{"issue":"9","key":"5110_CR96","first-page":"e10376","volume":"12","author":"PK Mada","year":"2020","unstructured":"Mada PK, Adley S, Salda\u00f1a Koppel DA, Moore M, Malus ME, Alam MJ, Feldman M (2020) Predicting liver fibrosis in the hepatitis C population: concordance analysis between noninvasive scoring systems and percutaneous liver biopsy. Cureus 12(9):e10376","journal-title":"Cureus"},{"key":"5110_CR97","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13337-019-00542-5","volume":"30","author":"S Mahajan","year":"2019","unstructured":"Mahajan S, Gupta E, Kumar G, Sharma MK, Rawat V, Agarwal R (2019) Comparative evaluation of three rapid immunochromatographic test assays with chemiluminescent microparticle immunoassay for the detection of hepatitis C virus antibody. Virusdisease 30:373\u2013379","journal-title":"Virusdisease"},{"key":"5110_CR98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/infdis\/170.2.433","volume":"170","author":"P Marcellin","year":"1994","unstructured":"Marcellin P, Branger M, Benhamou JP, Courtois F, Elias A, Erlinger S, Martinot-Peignoux M, Level R (1994) Hepatitis C Virus (HCV) viremia in human immunodeficiency virusseronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay. J Infect Dis 170:433\u2013435","journal-title":"J Infect Dis"},{"key":"5110_CR99","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1128\/jcm.32.12.3008-3012.1994","volume":"32","author":"MG Marin","year":"1994","unstructured":"Marin MG, Albertini A, Puoti M, Ravaggi A, Rodella A, Cariani E, Gussago A, Bresciani S, Pizzocolo G (1994) Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection. J Clin Microbiol 32:3008\u20133012","journal-title":"J Clin Microbiol"},{"key":"5110_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-981-16-0267-2_6","volume":"1322","author":"MA Martinez","year":"2021","unstructured":"Martinez MA, Franco S (2021) Discovery and development of antiviral therapies for chronic hepatitis C Virus infection. Adv Exp Med Biol 1322:139\u2013157","journal-title":"Adv Exp Med Biol"},{"key":"5110_CR101","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1615\/CritRevEukaryotGeneExpr.2018025121","volume":"28","author":"MS Masoud","year":"2018","unstructured":"Masoud MS, Khalid H, Ashfaq UA (2018) Interferon-free regimen for hepatitis C: insight and management. Crit Rev Eukaryot Gene Expr 28:373\u2013384","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"5110_CR102","doi-asserted-by":"crossref","unstructured":"McCartney EM, Ralton L, Dawe J, Richmond J, Zobel J, Wigg A, Cock V, Tse EY, Rees T, Shaw D, Ferguson C (2024) Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities - the PROMPt Study. Clin Infect Dis ciae155","DOI":"10.1093\/cid\/ciae155"},{"key":"5110_CR103","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1590\/S0074-02762012000500016","volume":"107","author":"GBL Menezes","year":"2012","unstructured":"Menezes GBL, Zarife MA, Reis EAG, Duarte CAB, Reis MG, Silva Filho HPD, Krieger MA, Pereira FA, Carmo TMA (2012) Hepatitis C virus quantification in serum and saliva of HCV-infected patients. Mem Inst Oswaldo Cruz 107:680\u2013683","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5110_CR104","first-page":"717","volume":"167","author":"RJ Meshram","year":"2022","unstructured":"Meshram RJ, Gacche RN, Kathwate GH (2022) Progress, evolving therapeutic\/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Adv Virol 167:717\u2013736","journal-title":"Adv Virol"},{"key":"5110_CR105","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ajme.2017.11.004","volume":"54","author":"ED Metawlly","year":"2017","unstructured":"Metawlly ED, Noby Amer A, Mostafa Mostafa H, El Din EG, Abd El Kader O (2017) Low cost detection of hepatitis C virus RNA in HCV infected patients by SYBR Green I real-time PCR. Alexandria J Med 54:481\u2013485","journal-title":"Alexandria J Med"},{"key":"5110_CR106","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/v9050100","volume":"9","author":"Z Miao","year":"2017","unstructured":"Miao Z, Ran J, Xia X, Miao J, Xie Z, Feng Y (2017) Regulated entry of hepatitis C virus into hepatocytes. Viruses 9:100","journal-title":"Viruses"},{"key":"5110_CR107","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/095632020301400601","volume":"14","author":"K Moriishi","year":"2003","unstructured":"Moriishi K, Matsuura Y (2003) Mechanisms of hepatitis C virus infection. Antiviral Chem Chemother 14:285\u2013297","journal-title":"Antiviral Chem Chemother"},{"key":"5110_CR108","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1537-2995.2002.00052.x","volume":"42","author":"AS Muerhoff","year":"2002","unstructured":"Muerhoff AS, Jiang L, Shah DO, Gutierrez RA, Patel J, Garolis C, Kyrk CR, Leckie G, Frank A, Stewart JL, Dawson GJ (2002) Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay. Transfusion 42:349\u2013356","journal-title":"Transfusion"},{"key":"5110_CR109","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/2211068214563794","volume":"20","author":"R Mukherjee","year":"2015","unstructured":"Mukherjee R, Garcia N, Chaum M, Niemz A, Bollipalli N, Burns A, Rodden D, Chang F (2015) Diagnosis and management of hepatitis C virus infection. J Lab Autom 20:519\u2013538","journal-title":"J Lab Autom"},{"key":"5110_CR110","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/jir.2019.0049","volume":"39","author":"SK Na","year":"2019","unstructured":"Na SK, Choi EK, Cho YK, Lee SJ, Kim YN, Song BC (2019) Aspartate aminotransferase-to-platelet ratio or fibros-4 index predicts the development of hepatocellular carcinoma in chronic hepatitis C patients with sustained virologic response to interferon therapy. J Interferon Cytokine Res 39:703\u2013710","journal-title":"J Interferon Cytokine Res"},{"key":"5110_CR111","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00439-020-02136-4","volume":"139","author":"P Nahon","year":"2020","unstructured":"Nahon P, Cobat A (2020) Human genetics of HCV infection phenotypes in the era of direct-acting antivirals. Hum Genet 139:855\u2013863","journal-title":"Hum Genet"},{"key":"5110_CR112","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1039\/D0AY02045A","volume":"13","author":"V Narayanamurthy","year":"2021","unstructured":"Narayanamurthy V, Samsuri F, Bhuvaneshwari KS, Jeroish ZE (2021) Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 13:740\u2013763","journal-title":"Anal Methods"},{"key":"5110_CR113","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1128\/JVI.77.5.2922-2927.2003","volume":"77","author":"K Narayanan","year":"2003","unstructured":"Narayanan K, Maeda J, Makino S, Chen CJ (2003) Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol 77:2922\u20132927","journal-title":"J Virol"},{"key":"5110_CR114","first-page":"01","volume":"12","author":"K Naresh","year":"2023","unstructured":"Naresh K (2023) Hepatitis C Virus (HCV) Infection: Screening, Diagnosis, Therapy and Prevention. Int J Sci Res Rev 12:01\u201311","journal-title":"Int J Sci Res Rev"},{"key":"5110_CR115","doi-asserted-by":"crossref","unstructured":"Naseer M, Aljuboori A, Chela H (2019) Laboratory and Molecular Diagnosis of Hepatitis C and Resistance Testing. Springer, pp 25\u201358","DOI":"10.1007\/978-3-030-03757-4_2"},{"key":"5110_CR116","doi-asserted-by":"crossref","unstructured":"Nolte FS (2001) Detection and Typing of Hepatitis C Virus. Humana, pp 363\u2013378","DOI":"10.1385\/1-59259-081-0:363"},{"key":"5110_CR117","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1039\/D2AN01761J","volume":"148","author":"F Ozefe","year":"2023","unstructured":"Ozefe F, Yildiz AA (2023) Fabrication and development of a microfluidic paper-based immunosorbent assay platform (\u03bcPISA) for colorimetric detection of hepatitis C. Analyst 148:898\u2013905","journal-title":"Analyst"},{"key":"5110_CR118","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/OGX.0000000000000442","volume":"72","author":"CM Page","year":"2017","unstructured":"Page CM, Kuller JA, Rhee EHJ, Hughes BL (2017) Hepatitis C in pregnancy: review of current knowledge and updated recommendations for management. Obstet Gynecol Surv 72:347\u2013355","journal-title":"Obstet Gynecol Surv"},{"key":"5110_CR119","doi-asserted-by":"publisher","first-page":"S328","DOI":"10.1093\/infdis\/jiad269","volume":"229","author":"K Page","year":"2023","unstructured":"Page K, Feinberg J (2023) What hepatitis C virus (HCV) diagnostic tools are needed to advance diagnosis of current HCV infection in outreach settings and in a nonclinical setting? J Infect Dis 229:S328\u2013S333","journal-title":"J Infect Dis"},{"key":"5110_CR120","unstructured":"Pang L, Zhang J (2018) Relationship between serum HCV-RNA level and liver function in patients with hepatitis C. 45:39\u201341"},{"key":"5110_CR121","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1556\/oh.2010.28978","volume":"151","author":"A P\u00e1r","year":"2010","unstructured":"P\u00e1r A, P\u00e1r G (2010) Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan). Orv Hetil 151:1951\u20131955","journal-title":"Orv Hetil"},{"key":"5110_CR122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1477-2574.2012.00465.x","volume":"14","author":"A Pesce","year":"2012","unstructured":"Pesce A, Scilletta R, Branca A, Nigro L, Montineri A, Larocca L, Fatuzzo F, Castaing M, Puleo S (2012) Does transient elastography (FibroScan\u00ae) have a role in decision making in hepatocellular carcinoma? HPB 14:403\u2013408","journal-title":"HPB"},{"key":"5110_CR123","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/v16050803","volume":"16","author":"BG Pierce","year":"2024","unstructured":"Pierce BG, Felbinger N, Metcalf M, Toth EA, Ofek G, Fuerst TR (2024) Hepatitis C Virus E1E2 structure, diversity, and implications for vaccine development. Viruses 16:803","journal-title":"Viruses"},{"key":"5110_CR124","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/v4102233","volume":"4","author":"D Pi\u00f1eiro","year":"2012","unstructured":"Pi\u00f1eiro D, Martinez-Salas E (2012) RNA structural elements of hepatitis C virus controlling viral RNA translation and the implications for viral pathogenesis. Viruses 4:2233\u20132250","journal-title":"Viruses"},{"key":"5110_CR125","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jviromet.2018.08.019","volume":"261","author":"L Poiteau","year":"2018","unstructured":"Poiteau L, Soulier A, Lemoine M, Mohammed Z, Wlassow M, Rwegasha J, Pawlotsky JM, Chevaliez S (2018) Performance of a new rapid diagnostic test for the detection of antibodies to hepatitis C virus. J Virol Methods 261:153\u2013155","journal-title":"J Virol Methods"},{"key":"5110_CR126","doi-asserted-by":"publisher","first-page":"030100","DOI":"10.1063\/1.4968353","volume":"1788","author":"AA Prasetyo","year":"2017","unstructured":"Prasetyo AA (2017) VLPs of HCV local isolates for HCV immunoassay diagnostic approach in Indonesia. AIP Conference Proceedngs 1788:030100","journal-title":"AIP Conference Proceedngs"},{"key":"5110_CR127","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.3390\/jcm10173951","volume":"10","author":"D Przekop","year":"2021","unstructured":"Przekop D, Golaszewski S, Gietka A, Panasiuk A, Grytczuk A, Cylwik B, Klapaczynski J, Gruszewska E, Chrostek L (2021) Non-invasive indirect markers of liver fibrosis after interferon-free treatment for hepatitis C. J Clin Med 10:3951","journal-title":"J Clin Med"},{"key":"5110_CR128","doi-asserted-by":"publisher","first-page":"25729","DOI":"10.1038\/srep25729","volume":"6","author":"P R\u00edos-Marco","year":"2016","unstructured":"R\u00edos-Marco P, Romero-L\u00f3pez C, Berzal-Herranz A (2016) The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation. Sci Rep 6:25729","journal-title":"Sci Rep"},{"key":"5110_CR129","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-8976-8_14","volume":"1911","author":"AE Roder","year":"2018","unstructured":"Roder AE, Horner SM (2018) Measuring hepatitis C virus envelopment by using a proteinase K protection assay. Methods Mol Biol (Clifton, NJ) 1911:209\u2013217","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"5110_CR130","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/jhep.2001.20534","volume":"33","author":"S Saadeh","year":"2001","unstructured":"Saadeh S (2001) The role of liver biopsy in chronic hepatitis C. Hepatology 33:196\u2013200","journal-title":"Hepatology"},{"key":"5110_CR131","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4254\/wjh.v14.i7.1333","volume":"14","author":"ZNA Said","year":"2022","unstructured":"Said ZNA, El-Sayed MH (2022) Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World J Hepatol 14:1333\u20131343","journal-title":"World J Hepatol"},{"key":"5110_CR132","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/jvh.13343","volume":"27","author":"ME Saine","year":"2020","unstructured":"Saine ME, Holmes JH, Mitra N, Szymczak JE, Bamford LP, Moore TM, Lo Re V, Schnittker J, Barg FK (2020) Determinants of stigma among patients with hepatitis C virus infection. J Viral Hepatitis 27:1179\u20131189","journal-title":"J Viral Hepatitis"},{"key":"5110_CR133","doi-asserted-by":"publisher","first-page":"e0258143","DOI":"10.1371\/journal.pone.0258143","volume":"16","author":"ME Saine","year":"2021","unstructured":"Saine ME, Szymczak JE, Moore TM, Bamford LP, Barg FK, Forde KA, Schnittker J, Holmes JH, Mitra N, Lo Re V (2021) The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection. PLoS ONE 16:e0258143","journal-title":"PLoS ONE"},{"key":"5110_CR134","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/microorganisms12061035","volume":"12","author":"M Sallam","year":"2024","unstructured":"Sallam M, Sallam M, Khalil R (2024) Contemporary insights into hepatitis C virus: a comprehensive review. Microorganisms 12:1035","journal-title":"Microorganisms"},{"key":"5110_CR135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/HMER.S470344","volume":"16","author":"I Salomon","year":"2024","unstructured":"Salomon I, Olivier S, Egide N (2024) Advancing hepatitis C elimination in Africa: insights from Egypt. Hepat Med 16:37\u201344","journal-title":"Hepat Med"},{"key":"5110_CR136","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/14787210.2024.2328336","volume":"22","author":"N Schiano Moriello","year":"2024","unstructured":"Schiano Moriello N, Pinchera B, Gentile I (2024) Personalized care approaches to hepatitis C therapy: recent advances and future directions. Expert Rev Anti Infect Ther 22:139\u2013151","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5110_CR137","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3748\/wjg.v20.i11.2854","volume":"20","author":"LDL Schiavon","year":"2014","unstructured":"Schiavon LDL (2014) Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 20:2854","journal-title":"World J Gastroenterol"},{"key":"5110_CR138","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1586\/14737159.8.4.369","volume":"8","author":"M Schutten","year":"2008","unstructured":"Schutten M (2008) Comparison of the Abbott RealtimeTM HIV-1 and HCV viral load assays with commercial competitor assays. Expert Rev Mol Diagn 8:369\u2013377","journal-title":"Expert Rev Mol Diagn"},{"key":"5110_CR139","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcv.2004.10.005","volume":"32","author":"K Seme","year":"2004","unstructured":"Seme K, Vince A, Poljak M, Babi\u010d DZ, Mo\u010dilnik T (2004) The role of core antigen detection in management of hepatitis C: a critical review. J Clin Virol 32:92\u2013101","journal-title":"J Clin Virol"},{"key":"5110_CR140","first-page":"1253","volume":"11","author":"I Shahid","year":"2021","unstructured":"Shahid I, Hassan S, Rehman S, Alzahrani AR, Alanazi IM, Al-Ghamdi SS (2021) Hepatitis C diagnosis: simplified solutions, predictive barriers, and future promises. Diagnostics (Basel, Switzerland) 11:1253","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"5110_CR141","doi-asserted-by":"crossref","unstructured":"Shaji LK, Satyasai B, Tejashree A, Deepashree R, Sujatha SR (2022) Comparative evaluation of chemiluminescence immunoassay and immunochromatograhic test with ELISA for detection of HCV infection. Int J Health Sci 3044\u20133053","DOI":"10.53730\/ijhs.v6nS9.13195"},{"key":"5110_CR142","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/bios12050298","volume":"12","author":"S Sharma","year":"2022","unstructured":"Sharma S, Thomas E, Caputi M, Asghar W (2022) RT-LAMP-based molecular diagnostic set-up for rapid hepatitis C virus testing. Biosensors 12:298","journal-title":"Biosensors"},{"key":"5110_CR143","doi-asserted-by":"crossref","unstructured":"Sheiko MA, Rosen HR (2016) Hepatic Fibrosis in Hepatitis C. springer japan, pp 79\u2013108","DOI":"10.1007\/978-4-431-56101-9_3"},{"key":"5110_CR144","first-page":"15","volume-title":"Hepatitis C Virus Genotypes and Their Evolution","author":"IT Shin","year":"2016","unstructured":"Shin IT, Mizokami M, Sugiyama M (2016) Hepatitis C Virus Genotypes and Their Evolution. Springer, Japan, pp 15\u201329"},{"key":"5110_CR145","first-page":"100489","volume":"19","author":"S Siavashy","year":"2024","unstructured":"Siavashy S, Soltani M, Rahimi S, Hosseinali M, Guilandokht Z, Raahemifar K (2024) Recent advancements in microfluidic-based biosensors for detection of genes and proteins: Applications and techniques. Biosensors and Bioelectronics: X 19:100489","journal-title":"Biosensors and Bioelectronics: X"},{"key":"5110_CR146","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3350\/cmh.2017.0033","volume":"23","author":"DH Sinn","year":"2017","unstructured":"Sinn DH, Kim YJ, Kim DY, Cho EJ, Choi MS, Kim JH (2017) Current status and strategies for viral hepatitis control in Korea. Clin Mol Hepatol 23:189\u2013195","journal-title":"Clin Mol Hepatol"},{"key":"5110_CR147","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/ndt\/gfy230","volume":"34","author":"ME Sise","year":"2018","unstructured":"Sise ME (2018) Hepatitis C virus infection and the kidney. Nephrol, Dial, Transplant: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc 34:415\u2013418","journal-title":"Nephrol, Dial, Transplant: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"issue":"1","key":"5110_CR148","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12985-019-1242-5","volume":"16","author":"HK Soliman","year":"2019","unstructured":"Soliman HK, Abouelhoda M, El Rouby MN, Ahmed OS, Esmat G, Hassan ZK, Hafez MM, Mehaney DA, Selvaraju M, Darwish RK, Osman YA (2019) Whole-genome sequencing of human Pegivirus variant from an Egyptian patient co-infected with hepatitis C virus: a case report. Virology Journal 16(1):132","journal-title":"Virology Journal"},{"key":"5110_CR149","first-page":"121","volume":"08","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Vatsalya V, Singh KP, Karch RC (2018) Developments in the diagnostic techniques of infectious diseases: rural and urban prospective. Adv Infect Dis 08:121\u2013138","journal-title":"Adv Infect Dis"},{"issue":"8","key":"5110_CR150","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3390\/cancers15082388","volume":"15","author":"T Stroffolini","year":"2023","unstructured":"Stroffolini T, Stroffolini G (2023) A historical overview on the role of hepatitis B and C viruses as aetiological factors for hepatocellular carcinoma. Cancers 15(8):2388","journal-title":"Cancers"},{"issue":"7","key":"5110_CR151","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071115","volume":"16","author":"T Stroffolini","year":"2024","unstructured":"Stroffolini T, Stroffolini G (2024) Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review. Viruses 16(7):1115","journal-title":"Viruses"},{"key":"5110_CR152","first-page":"28","volume":"4","author":"M Syamson","year":"2021","unstructured":"Syamson M, Murtini M, Asnuddin A, Yurniati Y (2021) Infection control and practice of standard precautions among hospital staff nurses in Indonesia. Malahayati Int J Nurs Health Sci 4:28\u201334","journal-title":"Malahayati Int J Nurs Health Sci"},{"key":"5110_CR153","doi-asserted-by":"publisher","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","volume":"10","author":"K Tabata","year":"2019","unstructured":"Tabata K, Neufeldt CJ, Bartenschlager R (2019) Hepatitis C Virus Replication. Cold Spring Harb Perspect Med 10:a037093","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5110_CR154","first-page":"38","volume":"13","author":"AA Tabll","year":"2023","unstructured":"Tabll AA, Smolic M, Ali AA, Siber S, Petrovic A, Smolic R, Glasnovic M, Sohrab SS, Steiner Srdarevic S (2023) Future prospects, approaches, and the government\u2019s role in the development of a hepatitis C virus vaccine. Pathogens (Basel, Switzerland) 13:38","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"5110_CR155","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1093\/infdis\/jiad299","volume":"229","author":"N Terrault","year":"2023","unstructured":"Terrault N (2023) Down-classification of hepatitis C virus diagnostics: implications for screening and diagnosis. J Infect Dis 229:S322\u2013S327","journal-title":"J Infect Dis"},{"key":"5110_CR156","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1016\/S0168-8278(16)00666-8","volume":"64","author":"E Thomson","year":"2016","unstructured":"Thomson E, Ip CL, Badhan A, Christiansen MT, Adamson W, Ansari MA, Bibby D, Breuer J, Brown A, Bowden R, Bryant J (2016) Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes. J Hepatol 64:S415","journal-title":"J Hepatol"},{"key":"5110_CR157","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-2004-813429","volume":"43","author":"H Tillmann","year":"2005","unstructured":"Tillmann H, Glomb I, Jelineck A, Wedemeyer H, Manns M, Picchio G, Wiegand J (2005) Diagnostic algorithm for chronic hepatitis c virus infection: role of the new HCV-core antigen assay. Z Gastroenterol 43:11\u201316","journal-title":"Z Gastroenterol"},{"key":"5110_CR158","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3389\/fimmu.2018.01411","volume":"9","author":"Y Tong","year":"2018","unstructured":"Tong Y, Zhong J, Li Q, Lavillette D (2018) Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly. Front Immunol 9:1411","journal-title":"Front Immunol"},{"key":"5110_CR159","doi-asserted-by":"publisher","first-page":"e30608","DOI":"10.1097\/MD.0000000000030608","volume":"101","author":"HA Torres","year":"2022","unstructured":"Torres HA, Champlin R, Raad I, Mustafayev K, Yibirin M, Angelidakis G, Orlowski R, Jiang Y, Economides M, Verstovsek S (2022) Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies. Medicine 101:e30608","journal-title":"Medicine"},{"issue":"2","key":"5110_CR160","first-page":"201","volume":"112","author":"E Treppo","year":"2020","unstructured":"Treppo E, Ragab G, Quartuccio L, De Vita S (2020) Rheumatologic manifestations of Hepatitis C Virus. Minerva Med 112(2):201\u2013214","journal-title":"Minerva Med"},{"key":"5110_CR161","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3748\/wjg.v22.i4.1367","volume":"22","author":"P Valva","year":"2016","unstructured":"Valva P (2016) Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 22:1367","journal-title":"World J Gastroenterol"},{"key":"5110_CR162","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/ph17081022","volume":"17","author":"EJ Vidal-Alc\u00e1ntara","year":"2024","unstructured":"Vidal-Alc\u00e1ntara EJ, Y\u00e9lamos MB, Mart\u00ednez I, Resino S, Rueda P, Ant\u00f3n SH, Fresco-Taboada A, G\u00f3mez J (2024) Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen. Pharmaceuticals (Basel, Switzerland) 17:1022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"5110_CR163","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s12879-022-07717-4","volume":"22","author":"LM Villar","year":"2022","unstructured":"Villar LM, de Lima MP, Cruz HM, de Paula VS, Scalioni LD, Flores GL, Carvalho-Costa FA, Parente CC, Coelho MR, de Albuquerque AC, Milagres FA (2022) Feasibility of dried blood spot for hepatitis C diagnosis in vulnerable subjects and people living in remote areas from Brazil. BMC Infect Dis 22(1):804","journal-title":"BMC Infect Dis"},{"key":"5110_CR164","doi-asserted-by":"publisher","first-page":"a037366","DOI":"10.1101\/cshperspect.a037366","volume":"10","author":"A Virz\u00ec","year":"2019","unstructured":"Virz\u00ec A, Roca Suarez AA, Lupberger J, Baumert TF (2019) Rewiring host signaling: hepatitis C virus in liver pathogenesis. Cold Spring Harb Perspect Med 10:a037366","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5110_CR165","doi-asserted-by":"publisher","first-page":"816238","DOI":"10.3389\/fcimb.2022.816238","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Ding P, Zhou J et al (2022) Rapid visual detection of hepatitis C virus using reverse transcription recombinase-aided amplification-lateral flow dipstick. Front Cell Infect Microbiol 12:816238","journal-title":"Front Cell Infect Microbiol"},{"key":"5110_CR166","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/v8050142","volume":"8","author":"H Wang","year":"2016","unstructured":"Wang H, Tai A (2016) Mechanisms of cellular membrane reorganization to support hepatitis C virus replication. Viruses 8:142","journal-title":"Viruses"},{"key":"5110_CR167","first-page":"845","volume":"31","author":"L Wei","year":"2008","unstructured":"Wei L, Yang R (2008) Progress and challenges in the laboratory diagnosis of hepatitis C virus. Chin J Lab Med 31:845\u2013848","journal-title":"Chin J Lab Med"},{"key":"5110_CR168","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/IM9.0000000000000117","volume":"5","author":"SC Weng","year":"2023","unstructured":"Weng SC, Zhou J, Zhong XY, Xin Q, Mai YX, Ji LQ, Li YP, Cao XJ, Yang WH, Chen HK, Guo XG (2023) Assessing the diagnostic accuracy of SD BIOLINE for detection of hepatitis C virus: a systematic review and meta-analysis. Infect Microbes Dis 5:76\u201382","journal-title":"Infect Microbes Dis"},{"issue":"7","key":"5110_CR169","doi-asserted-by":"publisher","first-page":"e00509","DOI":"10.14309\/ctg.0000000000000509","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Zhang X, Cao Y, Fan Z, Tian Y, Zou H, Ma Y, Duan Z, Ren F (2022) Digital droplet PCR (ddPCR) for detection and quantitation of hepatitis delta virus. Clin Transl Gastroenterol 13(7):e00509","journal-title":"Clin Transl Gastroenterol"},{"key":"5110_CR170","unstructured":"Zheng H, Wang H, Li Y (2008) The diagnosis and therapy of early De novo hepatitis C virus infection after liver transplantation. 29:228\u2013231"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05110-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:48:59Z","timestamp":1748342939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05110-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}